582 results on '"DE RE, VALLI"'
Search Results
2. Hepatic Progression of Hepatocellular Carcinoma
3. Dissecting the genetic heterogeneity of gastric cancer
4. Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis
5. Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer
6. The potential of retinoic acid receptors as prognostic biomarkers and therapeutic targets in gastric cancer.
7. Immunomodulation and Immunotherapy for Gastric Cancer
8. Genetic and Epigenetic Mechanisms in Gastric Cancer
9. Diagnosis and Surveillance: Endoscopic Hallmarks
10. How will the identification and therapeutic intervention of genetic targets in oncology evolve for future therapy?
11. Circulating Proteins as Diagnostic Markers in Gastric Cancer
12. Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer”
13. Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer
14. Preliminary Study of the Relationship between Osteopontin and Relapsed Hodgkin's Lymphoma.
15. Molecular Features Distinguishing Gastric Cancer Subtypes
16. Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors
17. Non-Classical HLA Class 1b and Hepatocellular Carcinoma
18. Supplementary Figure 1 from IGKV3 Proteins as Candidate “Off-the-Shelf” Vaccines for Kappa-Light Chain–Restricted B-Cell Non-Hodgkin Lymphomas
19. Supplementary Figure Legend and Tables 1 - 5 from IGKV3 Proteins as Candidate “Off-the-Shelf” Vaccines for Kappa-Light Chain–Restricted B-Cell Non-Hodgkin Lymphomas
20. Supplementary Figure 2 from IGKV3 Proteins as Candidate “Off-the-Shelf” Vaccines for Kappa-Light Chain–Restricted B-Cell Non-Hodgkin Lymphomas
21. A DSC Test for the Early Detection of Neoplastic Gastric Lesions in a Medium-Risk Gastric Cancer Area
22. Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing
23. Cancer treatment and the KIR–HLA system: an overview
24. Molecular Features of Lymphoproliferation in Mixed Cryoglobulinemia
25. Molecular Insights into the Disease Mechanisms of Type II Mixed Cryoglobulinemia
26. Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma
27. Prospective Evaluation of Different Methods for Volumetric Analysis on [18F]FDG PET/CT in Pediatric Hodgkin Lymphoma
28. Quantitative Plasma Proteomics to Identify Candidate Biomarkers of Relapse in Pediatric/Adolescent Hodgkin Lymphoma
29. Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis
30. The versatile role of gliadin peptides in celiac disease
31. Coagulation and fibrinolysis in gastric cancer
32. Association of Epstein-Barr Virus with Hodgkin’s Disease
33. HER2–CDH1 Interaction via Wnt/B-Catenin Is Associated with Patients’ Survival in HER2-Positive Metastatic Gastric Adenocarcinoma
34. KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive Breast Cancer
35. Pepsinogens to Distinguish Patients With Gastric Intestinal Metaplasia and Helicobacter pylori Infection Among Populations at Risk for Gastric Cancer
36. Differential Proteomics of Helicobacter pylori Associated with Autoimmune Atrophic Gastritis
37. Pegylated interferon-α, ribavirin, and rituximab combined therapy of hepatitis C virus–related mixed cryoglobulinemia: a long-term study
38. Prospective Evaluation of Different Methods for Volumetric Analysis on [ 18 F]FDG PET/CT in Pediatric Hodgkin Lymphoma.
39. A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy
40. Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas
41. Proteomic Analyses Lead to a Better Understanding of Celiac Disease: Focus on Epitope Recognition and Autoantibodies
42. PPAR Signaling Pathway and Cancer-Related Proteins Are Involved in Celiac Disease-Associated Tissue Damage
43. MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer
44. Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis
45. Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence
46. The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
47. Biomarkers and OLGIM Stage for Prospective Preneoplastic Risk Stratification
48. Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
49. Low frequency of bcl-2 rearrangement in HCV-associated non-Hodgkin's lymphoma tissue
50. 2-D Gel Electrophoresis: Constructing 2D-Gel Proteome Reference Maps
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.